Howard Suh is a partner in Holland & Knight’s New York office. Mr. Suh focuses his intellectual property practice on patent litigation and counseling, with an emphasis on pharmaceuticals and biotechnology. He has tried some of the largest patent cases in these areas, and is active in appellate litigation at the Federal Circuit and Supreme Court.
In the biotechnology sector, Mr. Suh has litigated and provided advice on patents related to some of the most important biopharmaceuticals, including recombinantly-produced insulin, human growth hormone (HGH), tissue plasminogen activator (t-PA), erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF) and chimeric antibodies.
Mr. Suh also has substantial experience in agricultural biotechnology, having represented multinational crop-sciences companies in patent litigation involving genetically modified corn and soybean seeds.
On the pharmaceutical side, Mr. Suh has handled a wide variety of patent litigations on small-molecule drugs, in fields ranging from oncology and immunology to cough-and-cold products.
In addition, Mr. Suh has litigated patent cases in a variety of other fields, ranging from medical devices to material science. He also assists clients in corporate transactions and acquisitions, performing due diligence of patent portfolios, evaluating threats from competitive patents and preparing agreements.
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.